CellSonic VIPP, Owner'S Manual

Page: 51 / 51

51
In August 2018, Best Answer For Cancer was approved for its 5th IRB study:
“ Survival Outcomes Study for Stage III and IV Cancer/Chronic Disease Patients
with Pain Using IS/ESWT. ”
The Foundation ’ s intent with this study is to address that segment of the
population that has exhausted other avenues of treatment; have few financial
resources left; and who still suffer from cancer, chronic disease, and the pain
associated with both.
The protocol is positioned to increase their quality of life, by both lessening pain,
and supporting the body
’ s immune system. The protocol makes use of the
CellSonic VIPP machine and two supportive IV therapies.
To access the protocol, you need to be a member of Best Answer for Cancer
Foundation and sign a non
- closure agreement to receive further information
regarding your participation in the study. Contact BAFC at
admin@bestanswerforcancer.org
Best Answer for Cancer Foundation ’ s mission is to improve the quality of
life and treatment of cancer and chronic disease patients with a holistic
platform, targeted therapies, and a patient
- centered approach. Best
Answer for Cancer Foundation (BAFC) believes the best standard of care
is one that provides the best quality of life during treatment and the best
outlook for a long, vital life.
We are a hybrid organization of doctors and patients working to shift the
disease paradigm from a one
- size - fits - all disease - based approach to a
patient - centered, integrative medical approach. We support integrative
oncology that addresses the disease while considering the uniqueness of
each patient.
The physician membership arm of BAFC includes our annual conferences
and the International Organization of Integrative Physicians (IOIP)
through which members share and access information with doctors
around the world.
IRB Study
This goes as a separate,
stand
- alone sheet in the
3 - ring binder, given to
the appropriate buyers.